|
CDC26 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.55111512312578E-16 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.68309810533174E-12 |
| Normal-vs-Stage2 |
1.5663999985982E-08 |
| Normal-vs-Stage3 |
1.62614366416847E-12 |
| Normal-vs-Stage4 |
1.69364522406568E-12 |
| Stage1-vs-Stage2 |
6.868400E-01 |
| Stage1-vs-Stage3 |
2.878300E-02 |
| Stage1-vs-Stage4 |
6.264600E-03 |
| Stage2-vs-Stage3 |
7.277900E-02 |
| Stage2-vs-Stage4 |
1.367550E-02 |
| Stage3-vs-Stage4 |
3.693800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62680979798324E-12 |
| Normal-vs-AfricanAmerican |
1.30430000133686E-08 |
| Normal-vs-Asian |
1.43720002565573E-09 |
| Caucasian-vs-AfricanAmerican |
5.786200E-01 |
| Caucasian-vs-Asian |
6.396800E-01 |
| AfricanAmerican-vs-Asian |
3.968000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62581059726108E-12 |
| Normal-vs-Female |
1.62836411021772E-12 |
| Male-vs-Female |
1.856820E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.21804821573824E-14 |
| Normal-vs-Age(41-60Yrs) |
4.80726569662693E-14 |
| Normal-vs-Age(61-80Yrs) |
1.62658775337832E-12 |
| Normal-vs-Age(81-100Yrs) |
3.19030002415843E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.863000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.227560E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.317800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.241610E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.057500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.050000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.290010E-02 |
| Classical-VS-Follicular |
6.651200E-01 |
| Classical-VS-Other |
9.526600E-01 |
| Classical-VS-Normal |
1.62536650805123E-12 |
| Tall-VS-Follicular |
3.316100E-02 |
| Tall-VS-Other |
4.344000E-01 |
| Tall-VS-Normal |
1.81288317691042E-12 |
| Follicular-VS-Other |
9.563200E-01 |
| Follicular-VS-Normal |
3.16080051021572E-10 |
| Other-VS-Normal |
8.468000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.78179693222091E-12 |
| Normal-vs-N1 |
2.66453525910038E-15 |
| N0-vs-N1 |
1.675080E-03 |
|
|
